TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11172506

Group type: EXPERIMENTAL
Intervention: CSE set with interlocking device (Group 1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CSE set with 'backeye' (Group 2)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Double-segment technique (Group 3)
Number of subjects: 90

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group 1
Number of subjects: 90
Study: 9883434

Group type: EXPERIMENTAL
Intervention: CTG (1.2% clindamycin phosphate, 0.025% tretinoin gel)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Tretinoin gel (0.025%)
Number of subjects: 145
Study: 8533564

Group type: EXPERIMENTAL
Intervention: Spironolactone 100 mg daily
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 11527111

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 150

Group type: COMPARATOR
Intervention: Off treatment
Number of subjects: 150
Study: 696747

Group type: EXPERIMENTAL
Intervention: Theophylline 16 mg/kg/day
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30607928

Group type: EXPERIMENTAL
Intervention: RAPN with ischemia
Number of subjects: 0

Group type: COMPARATOR
Intervention: RAPN without ischemia
Number of subjects: 0
Study: 27049596

Group type: EXPERIMENTAL
Intervention: Cued-recall test on 'old' pairs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Restudy of 'old' pairs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cued-recall test with intermixed 'new' and 'old' pairs
Number of subjects: 0
Study: 24562697

Group type: EXPERIMENTAL
Intervention: DonJoy (DJO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polar Care 300 (PC300)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polar Care 500 Lite (PC500L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DeRoyal T505 (DR505)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All devices during rewarming period
Number of subjects: 0
Study: 24187115

Group type: EXPERIMENTAL
Intervention: DOVE intervention (10-minute brochure-based IPV intervention and nurse home visitation)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 239
Study: 21131142

Group type: EXPERIMENTAL
Intervention: Salvinorin A (doses ranged from 0.375 μg/kg to 21 μg/kg)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Salvinorin A
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 19032459

Group type: EXPERIMENTAL
Intervention: PEG‐I at 1 microg/kg plus RBV for 24 weeks
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: PEG‐I at 1.5 microg/kg plus RBV for 24 weeks
Number of subjects: 55
Study: 17954654

Group type: EXPERIMENTAL
Intervention: Perioperative placement of occlusion balloons within the internal iliac arteries
Number of subjects: 11
Study: 15234295

Group type: EXPERIMENTAL
Intervention: Yellow UV intraocular lenses (IOLs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ordinary UV intraocular lenses (IOLs)
Number of subjects: 60
Study: 16326336

Group type: EXPERIMENTAL
Intervention: 2-hour structured course on regional anesthesia techniques for pain management
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1-hour lecture tutorial on regional anesthesia techniques and 1 hour of bedside teaching
Number of subjects: 40
Study: 12791021

Group type: EXPERIMENTAL
Intervention: Transverse incision (T)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midline incision (M)
Number of subjects: 40
Study: 9062345

Group type: EXPERIMENTAL
Intervention: Intravenous CGP 51901 (3, 10, 30, and 100 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 8473790

Group type: COMPARATOR
Intervention: rh‐SOD (10000 U/kg) administered through the aortic root into the coronary artery prior to reperfusion (group II)
Number of subjects: 51

Group type: COMPARATOR
Intervention: rh‐SOD (10000 U/kg) administered into the cardiopulmonary circuit prior to reperfusion (group III)
Number of subjects: 51

Group type: COMPARATOR
Intervention: rh‐SOD (3000 U/kg) administered into the cardiopulmonary circuit prior to reperfusion (group IV)
Number of subjects: 51
Study: 2883043

Group type: EXPERIMENTAL
Intervention: Methyldopa (Aldomet)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 2655822

Group type: EXPERIMENTAL
Intervention: Lesser sac lavage
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lesser sac drainage
Number of subjects: 24
Study: 31652073

Group type: COMPARATOR
Intervention: Oral conjugated equine estrogens (0.45 mg/d)
Number of subjects: 727

Group type: COMPARATOR
Intervention: Transdermal 17β‐estradiol (50 µg/d)
Number of subjects: 727

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 727
Study: 27537410

Group type: EXPERIMENTAL
Intervention: Controlled frequency breathing (CFB) group, breathing every 7-10 strokes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group, breathing every 3-4 strokes
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 25603890

Group type: EXPERIMENTAL
Intervention: Retinol 0.2%/LR2412 2% cream
Number of subjects: 120

Group type: COMPARATOR
Intervention: tretinoin 0.025% cream
Number of subjects: 120
Study: 24189759

Group type: EXPERIMENTAL
Intervention: Intramuscular neridronate 25 mg administered once a month for 12 months
Number of subjects: 87

Group type: COMPARATOR
Intervention: Oral alendronate 70 mg administered once-weekly for 12 months
Number of subjects: 87

Group type: COMPARATOR
Intervention: Oral risedronate 35 mg administered once-weekly for 12 months
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: All groups (neridronate, alendronate, risedronate)
Number of subjects: 87
Study: 21427858

Group type: EXPERIMENTAL
Intervention: Discectomy combined with Isobar non-fusion internal fixation (Group A)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Single discectomy (Group B)
Number of subjects: 65
Study: 19865538

Group type: EXPERIMENTAL
Intervention: Quercetin supplementation (150 mg/day for 42 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quercetin (1, 10, 20 micromol/L) in RAW264.7 macrophages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isorhamnetin (methylated quercetin derivative)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quercetin-3-glucuronide (glucuronidated metabolite)
Number of subjects: 0
Study: 17712236

Group type: EXPERIMENTAL
Intervention: High-dose atomoxetine (up to 3.0 mg/kg/day in study 1; up to 2.4 mg/kg/day in study 2)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Continued same-dose atomoxetine
Number of subjects: 247
Study: 15070924

Group type: EXPERIMENTAL
Intervention: Polyunsaturated fat‐enriched ketogenic diet (POLY KD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saturated fatty acid‐enriched ketogenic diet (SAT KD)
Number of subjects: 20
Study: 11605930

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Thiopental
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 65
Study: 9677791

Group type: EXPERIMENTAL
Intervention: Bennett Cascade water‐bath humidifier
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fisher & Paykel servocontrolled humidifier
Number of subjects: 45

Group type: COMPARATOR
Intervention: HME Hygrobac DAR
Number of subjects: 45
Study: 8131528

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (4 g IV over 30 min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Terbutaline (0.25 mg SC)
Number of subjects: 0
Study: 2679244

Group type: EXPERIMENTAL
Intervention: Theo-Dur tablets (200 mg theophylline anhydrous sustained-release) taken in the evening with food
Number of subjects: 0

Group type: COMPARATOR
Intervention: Theo-Dur tablets (200 mg theophylline anhydrous sustained-release) taken in the evening without food
Number of subjects: 0
Study: 1211837

Group type: EXPERIMENTAL
Intervention: 8 mm diameter metal cannula
Number of subjects: 300

Group type: COMPARATOR
Intervention: Flexible plastic cannula
Number of subjects: 300
Study: 31504091

Group type: EXPERIMENTAL
Intervention: Placebo treatment with no choice
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Placebo treatment with choice (single or daily)
Number of subjects: 117

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 117
Study: 31237547

Group type: EXPERIMENTAL
Intervention: On-pump CABG without carbohydrate preoperative oral feeding
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: On-pump CABG with carbohydrate preoperative oral feeding
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Off-pump CABG without carbohydrate preoperative oral feeding
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Off-pump CABG with carbohydrate preoperative oral feeding
Number of subjects: 80
Study: 28192584

Group type: EXPERIMENTAL
Intervention: OCT-based scanned capsule centration (SCC) with three-piece IOL
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: OCT-based scanned capsule centration (SCC) with plate-haptic IOL
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Pupil centration (PC) with three-piece IOL
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Pupil centration (PC) with plate-haptic IOL
Number of subjects: 160
Study: 25490004

Group type: EXPERIMENTAL
Intervention: Platinum sensitive
Number of subjects: 329

Group type: COMPARATOR
Intervention: Refractory
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Elevated serum lactate dehydrogenase
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Performance status of 1
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Weight loss ≥ 5%
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Platinum sensitivity status
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Platinum sensitivity status excluding 36 patients with multiple prior regimens
Number of subjects: 329
Study: 23857420

Group type: EXPERIMENTAL
Intervention: Responders (those who returned questionnaires)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Non-responders (those who did not return questionnaires)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Both groups (responders and non-responders)
Number of subjects: 194
Study: 20670468

Group type: EXPERIMENTAL
Intervention: Probiotic drink containing Lactobacillus casei strain Shirota
Number of subjects: 3758

Group type: COMPARATOR
Intervention: Nutrient drink
Number of subjects: 3758

Group type: EXPERIMENTAL
Intervention: Probiotic drink
Number of subjects: 3758
Study: 19374155

Group type: EXPERIMENTAL
Intervention: 0.2 mL/kg ropivacaine 0.75% (group R)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.2 mL/kg saline 0.9% (group F)
Number of subjects: 60
Study: 17426611

Group type: EXPERIMENTAL
Intervention: 4 different interventions
Number of subjects: 1

Group type: COMPARATOR
Intervention: Full-factorial design
Number of subjects: 1
Study: 14768298

Group type: EXPERIMENTAL
Intervention: Caspofungin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Voriconazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amphotericin B
Number of subjects: 0
Study: 11465587

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS) combined with physical therapy (PT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Physical therapy (PT)
Number of subjects: 54
Study: 9488072

Group type: EXPERIMENTAL
Intervention: Transurethral resection of the prostate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transurethral incision of the prostate
Number of subjects: 0
Study: 7961547

Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants (type IA antiarrhythmics)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Class I antiarrhythmic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serotonin selective reuptake inhibitors or bupropion
Number of subjects: 0
Study: 3288434

Group type: EXPERIMENTAL
Intervention: 1.14% sodium monofluorophosphate (1500 ppm F) dentifrice
Number of subjects: 2415

Group type: COMPARATOR
Intervention: 0.76% sodium monofluorophosphate (1000 ppm F) dentifrice
Number of subjects: 2415
Study: 30005049

Group type: EXPERIMENTAL
Intervention: 20 μg teriparatide (PTH)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 27580156

Group type: EXPERIMENTAL
Intervention: Ischemic Preconditioning (IPC)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sham Intervention (SHAM)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (CT)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All interventions (IPC, SHAM, CT)
Number of subjects: 18
Study: 28638192

Group type: EXPERIMENTAL
Intervention: Horticultural therapy (12 weeks, 3 times a week, 90 minutes per session)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (normal medications only)
Number of subjects: 110
Study: 25536255

Group type: EXPERIMENTAL
Intervention: Comprehensive care
Number of subjects: 201

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 201
Study: 22903151

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community-based approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise trial
Number of subjects: 0
Study: 19244038

Group type: EXPERIMENTAL
Intervention: Uncertain diagnosis group (73 patients)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Known benign group (37 patients)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Known malignant group (16 patients)
Number of subjects: 150
Study: 17295900

Group type: EXPERIMENTAL
Intervention: Systemic TNF‐α and IFN‐γ levels in pregnant women (n = 51)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Systemic TNF‐α and IFN‐γ levels in not pregnant women (n = 75)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Systemic TNF‐α and IFN‐γ levels in women who miscarried (n = 13)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Systemic TNF‐α and IFN‐γ levels in women who had a live birth (n = 38)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Systemic TNF‐α and IFN‐γ levels in women with high activated NK cells (n = 39)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Systemic TNF‐α and IFN‐γ levels in women with low activated NK cells (n = 87)
Number of subjects: 126
Study: 15449653

Group type: EXPERIMENTAL
Intervention: Radish containing diet
Number of subjects: 36

Group type: COMPARATOR
Intervention: Self‐selected diet
Number of subjects: 36
Study: 11794743

Group type: EXPERIMENTAL
Intervention: Linseed extract Salinum alone (Sal)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Linseed extract Salinum with chlorhexidine (Sal/Chx)
Number of subjects: 22
Study: 9684641

Group type: EXPERIMENTAL
Intervention: Allopurinol (8.5 mg/kg of body weight/day for 60 days)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Itraconazole (6 mg/kg of body weight/day for 120 days)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Placebo (pure starch)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 404
Study: 7798370

Group type: EXPERIMENTAL
Intervention: Extremely low birth weight (ELBW) children
Number of subjects: 1868

Group type: EXPERIMENTAL
Intervention: Children with IQ scores above 85
Number of subjects: 1868
Study: 3182592

Group type: EXPERIMENTAL
Intervention: Theophylline (200 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Salbutamol (4 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Ephedrine (24 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Prednisolone (10 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Epinephrine (1:1000, 0.5 ml subcutaneously)
Number of subjects: 23
Study: 31637577

Group type: EXPERIMENTAL
Intervention: Cabozantinib 40 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cabozantinib 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cabozantinib 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27188890

Group type: EXPERIMENTAL
Intervention: Left-behind children (LBC)
Number of subjects: 827

Group type: COMPARATOR
Intervention: Non-left-behind children (non-LBC)
Number of subjects: 827
Study: 24287370

Group type: EXPERIMENTAL
Intervention: Nanosomal docetaxel lipid suspension (NDLS)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Taxotere (75 mg/m2)
Number of subjects: 72
Study: 23179200

Group type: EXPERIMENTAL
Intervention: Lifestyle counseling + 30 g/day flaxseed supplementation (LCF)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Lifestyle counseling (LC)
Number of subjects: 173
Study: 20639722

Group type: COMPARATOR
Intervention: Aerobic exercise training (A group)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Resistance exercise training (R group)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Combined aerobic and resistance training (A + R group)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Sedentary lifestyle (C group)
Number of subjects: 251
Study: 18981208

Group type: EXPERIMENTAL
Intervention: Audience Response System (ARS)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Conventional lectures
Number of subjects: 77
Study: 15640601

Group type: EXPERIMENTAL
Intervention: 5% citrate lock
Number of subjects: 28

Group type: COMPARATOR
Intervention: 10% citrate lock
Number of subjects: 28
Study: 12531794

Group type: EXPERIMENTAL
Intervention: CHOP with G-CSF
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: CHOP without G-CSF
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: CNOP with G-CSF
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: CNOP without G-CSF
Number of subjects: 455

Group type: COMPARATOR
Intervention: G-CSF
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: CHOP
Number of subjects: 455

Group type: COMPARATOR
Intervention: CNOP
Number of subjects: 455
Study: 10812254

Group type: EXPERIMENTAL
Intervention: EMLA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 8668508

Group type: EXPERIMENTAL
Intervention: Appropriate order of reporting stimulus-dimension values
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical identification
Number of subjects: 0

Group type: COMPARATOR
Intervention: Identification of meaning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Redundant color coding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stimulus location
Number of subjects: 0

Group type: COMPARATOR
Intervention: Difficulty of the dual task
Number of subjects: 0
Study: 8214043

Group type: EXPERIMENTAL
Intervention: Intralipid infusion (10%; 30 ml/h)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (0.154 mol/l NaCl)
Number of subjects: 7
Study: 3767596

Group type: EXPERIMENTAL
Intervention: Intravenous tryptophan
Number of subjects: 44

Group type: COMPARATOR
Intervention: Long-term alprazolam treatment
Number of subjects: 44
Study: 30220368

Group type: EXPERIMENTAL
Intervention: Self-reported perceived exertion with automatic internet-based feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: IMT with 30% maximal inspiratory pressure without feedback
Number of subjects: 0
Study: 24366521

Group type: EXPERIMENTAL
Intervention: 12 sexual health phone counseling contacts over 24 months
Number of subjects: 701

Group type: COMPARATOR
Intervention: 12 general health phone counseling contacts over 24 months
Number of subjects: 701
Study: 22994875

Group type: EXPERIMENTAL
Intervention: Mitiglinide
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Voglibose
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mitiglinide/Voglibose combination
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 12
Study: 19747792

Group type: EXPERIMENTAL
Intervention: Immediate transfer for percutaneous coronary intervention (PCI)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Standard management in local hospitals (conservative group)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Immediate transfer for PCI
Number of subjects: 266
Study: 17921388

Group type: EXPERIMENTAL
Intervention: Chilenje Baby Mix (CBM); energy density: 68 kcal/100 g; n = 37
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Chilenje Baby Mix with alpha-amylase (CBMA); energy density: 106 kcal/100 g; n = 44
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group; n = 69
Number of subjects: 150
Study: 16150805

Group type: EXPERIMENTAL
Intervention: Trastuzumab + chemotherapy (doxorubicin/cyclophosphamide or paclitaxel)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vinorelbine + trastuzumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trastuzumab-based therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HER2 gene amplification
Number of subjects: 0
Study: 12383299

Group type: EXPERIMENTAL
Intervention: KTP laser tonsillectomy
Number of subjects: 151

Group type: COMPARATOR
Intervention: Conventional dissection tonsillectomy
Number of subjects: 151
Study: 10653049

Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate (50/500 microg) via a single Diskus inhaler (combination)
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 microg and fluticasone propionate 500 microg administered via separate Diskus inhalers (concurrent)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Fluticasone propionate 500 microg and placebo
Number of subjects: 503
Study: 7608448

Group type: EXPERIMENTAL
Intervention: Losartan 25 mg/day
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg/day
Number of subjects: 166

Group type: COMPARATOR
Intervention: Enalapril 20 mg/day
Number of subjects: 166
Study: 2496815

Group type: EXPERIMENTAL
Intervention: Melatonin 5 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 998551

Group type: EXPERIMENTAL
Intervention: Dietary supplements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no dietary supplements)
Number of subjects: 0
Study: 30608989

Group type: EXPERIMENTAL
Intervention: DNA methylation levels of CADM1, FAM19A4, and MAL in cytologic HSIL
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: DNA methylation levels of CADM1, FAM19A4, and MAL in histologic HSIL+
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: FAM19A4 methylation for differentiating high-grade cytology
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: CADM1 methylation for distinguishing histologic HSIL+
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Combined high DNA methylation levels with HPV16/18 genotypes
Number of subjects: 260